Skip to content

Insider · CIK 0001975028

Jeremy R. Graff

directorofficer

Files at INAB (IN8BIO, INC.), ALLR (Allarity Therapeutics, Inc.). First filing -, latest -.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jan 22, 2026ALLR
Allarity Therapeutics, Inc.
MOption exercise
Common Stock
+48,147--73,0283 d ago
Jan 22, 2026ALLR
Allarity Therapeutics, Inc.
FTax withholding
Common Stock
-17,814$1.18$21k55,2143 d ago
Sep 30, 2026ALLR
Allarity Therapeutics, Inc.
MOption exercise
Common Stock
+39,494--94,7083 d ago
Sep 30, 2026ALLR
Allarity Therapeutics, Inc.
FTax withholding
Common Stock
-14,613$0.97$14k80,0953 d ago
Jan 22, 2026ALLR
Allarity Therapeutics, Inc.
MOption exercise
Restricted Stock Unitsderivative
-48,147$0.00$0175,2833 d ago
Sep 30, 2026ALLR
Allarity Therapeutics, Inc.
MOption exercise
Restricted Stock Unitsderivative
-39,494$0.00$0269,1223 d ago
May 8, 2025INAB
IN8BIO, INC.
AGrant or award
Stock Option (right to buy)derivative
+63,150$0.00$063,150May 12, 2025
Apr 27, 2025INAB
IN8BIO, INC.
DDisposition to issuer
Series B Warrants (right to buy)derivative
-2,049--0May 7, 2025
Apr 27, 2025INAB
IN8BIO, INC.
AGrant or award
Series B Warrants (right to buy)derivative
+2,049--2,049May 7, 2025
Jan 22, 2025ALLR
Allarity Therapeutics, Inc.
AGrant or award
Common Stock
+144,441$0.00$0262,924Jan 24, 2025
Dec 19, 2024INAB
IN8BIO, INC.
AGrant or award
Stock Option (right to buy)derivative
+47,697$0.00$047,697Dec 23, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Jeremy R. Graff: insider trades and track record | InsiderTell